Literature DB >> 24332406

Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.

David Fraguas1, Angel Del Rey-Mejías2, Carmen Moreno2, Josefina Castro-Fornieles3, Montserrat Graell4, Soraya Otero5, Ana Gonzalez-Pinto6, Dolores Moreno2, Inmaculada Baeza3, Mónica Martínez-Cengotitabengoa6, Celso Arango2, Mara Parellada2.   

Abstract

Longer duration of untreated psychosis (DUP) in adult patients with first-episode psychosis (FEP) has been associated with poor clinical and social outcomes. We aimed to estimate the influence of DUP on outcome at 2-year follow-up in subjects with an early-onset (less than 18 years of age) FEP of less than 6 months' duration. A total of 80 subjects (31.3% females, mean age 16.0±1.8 years) were enrolled in the study. The influence of DUP on outcome was estimated using multiple regression models (two linear models for influence of DUP on the C-GAF at 2 years and C-GAF change through the follow-up period, and a logistic model for influence of DUP on 41 PANSS remission at 2 years in schizophrenia patients (n=47)). Mean DUP was 65.3±54.7 days. Median DUP was 49.5 days. For the whole sample (n=80), DUP was the only variable significantly related to C-GAF score at 2-year follow-up (Beta=-0.13, p<0.01), while DUP and premorbid adjustment (Beta=-0.01, p<0.01; and Beta=-0.09, p=0.04, respectively) were the only variables significantly related to C-GAF change. In schizophrenia patients, DUP predicted both C-GAF score at 2 years and C-GAF change, while in patients with affective psychosis (n=22), DUP was unrelated to outcome. Lower baseline C-GAF score (OR=0.91, p<0.01) and shorter DUP (OR=0.98, p=<0.01) were the only variables that significantly predicted clinical remission in schizophrenia patients. In conclusion, longer DUP was associated with lower C-GAF at 2 years, less increase in C-GAF, and lower rates of clinical remission in early-onset FEP. Our findings support the importance of early detection programs, which help shorten DUP.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescent; Affective psychosis; Bipolar disorder; Duration of untreated psychosis (DUP); First-episode psychosis (FEP); Outcome; Remission; Schizophrenia

Mesh:

Year:  2013        PMID: 24332406     DOI: 10.1016/j.schres.2013.11.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis.

Authors:  Ángel Del Rey-Mejías; David Fraguas; Covadonga M Díaz-Caneja; Laura Pina-Camacho; Josefina Castro-Fornieles; Inmaculada Baeza; Ana Espliego; Jessica Merchán-Naranjo; Ana González-Pinto; Elena de la Serna; Beatriz Payá; Montserrat Graell; Celso Arango; Mara Parellada
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-03-01       Impact factor: 4.785

2.  Gender effects on brain changes in early-onset psychosis.

Authors:  Marta Rapado-Castro; Cali F Bartholomeusz; Josefina Castro-Fornieles; Ana González-Pinto; Soraya Otero; Inmaculada Baeza; Carmen Moreno; Montserrat Graell; Joost Janssen; Nuria Bargalló; Christos Pantelis; Manuel Desco; Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01-15       Impact factor: 4.785

3.  Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program.

Authors:  Ivy F Tso; Stephan F Taylor; Tyler B Grove; Tara Niendam; Steven Adelsheim; Andrea Auther; Barbara Cornblatt; Cameron S Carter; Roderick Calkins; J Daniel Ragland; Tamara Sale; William R McFarlane
Journal:  Early Interv Psychiatry       Date:  2014-12-21       Impact factor: 2.732

4.  Clinical high risk for psychosis paradigm for CAP: do not throw the baby out with the bathwater.

Authors:  Paul Klauser; Alexis Revet; Dimitri Anagnostopoulos; Johannes Hebebrand; Carmen Moreno; Jean-Philippe Raynaud; Marco Armando
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-08-24       Impact factor: 4.785

Review 5.  Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.

Authors:  Sabina Abidi; Irfan Mian; Iliana Garcia-Ortega; Tania Lecomte; Thomas Raedler; Kevin Jackson; Kim Jackson; Tamara Pringsheim; Donald Addington
Journal:  Can J Psychiatry       Date:  2017-08-02       Impact factor: 4.356

6.  First episode of psychosis in a middle-aged patient with a 14-year history of conversion disorder.

Authors:  Vaios Peritogiannis; Thiresia Manthopoulou; Venetsanos Mavreas
Journal:  Case Rep Psychiatry       Date:  2014-12-18

7.  The Maudsley environmental risk score for psychosis.

Authors:  Evangelos Vassos; Pak Sham; Matthew Kempton; Antonella Trotta; Simona A Stilo; Charlotte Gayer-Anderson; Marta Di Forti; Cathryn M Lewis; Robin M Murray; Craig Morgan
Journal:  Psychol Med       Date:  2019-09-19       Impact factor: 7.723

8.  Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.

Authors:  Tak Lam Lo; Matthew Warden; Yanling He; Tianmei Si; Seshadri Kalyanasundaram; Manickam Thirunavukarasu; Nurmiati Amir; Ahmad Hatim; Tomas Bautista; Cheng Lee; Robin Emsley; Jose Olivares; Yen Kuang Yang; Ronnachai Kongsakon; David Castle
Journal:  Asia Pac Psychiatry       Date:  2016-06       Impact factor: 2.538

Review 9.  Predictors of outcome in early-onset psychosis: a systematic review.

Authors:  Covadonga M Díaz-Caneja; Laura Pina-Camacho; Alberto Rodríguez-Quiroga; David Fraguas; Mara Parellada; Celso Arango
Journal:  NPJ Schizophr       Date:  2015-03-04

10.  Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses.

Authors:  Olesya Ajnakina; Tushar Das; John Lally; Marta Di Forti; Carmine M Pariante; Tiago Reis Marques; Valeria Mondelli; Anthony S David; Robin M Murray; Lena Palaniyappan; Paola Dazzan
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.